Menu
Patients with a complex, chronic disorder don’t have a single cause for their disease. Each patient has a unique combination of genetic and environmental risk factors.
Ariel goes beyond genetics to provide valuable information to clarify risk and guide a personalized approach to the early detection of complex diseases such as pancreatitis and pancreatic cancer.
Our ADVANCE® platform analyses combines genetics, environmental and patient-specific data with clinical guidance supported by the most current scientific evidence to provide a comprehensive and actionable risk assessment to inform screening for early detection, risk-reducing strategies, and treatment.
